Mutations at a split codon in the GTPase-encoding domain of OPA1 cause dominant optic atrophy through different molecular mechanisms. [PDF]
Weisschuh N +6 more
europepmc +1 more source
An Integrated NLP‐ML Framework for Property Prediction and Design of Steels
This study presents a data‐driven framework that uses language‐processing techniques to interpret steel processing descriptions and machine‐learning models to predict mechanical properties. By organising complex process histories into meaningful groups and enabling rapid property forecasts, the work supports faster, more informed steel design through ...
Kiran Devraju +5 more
wiley +1 more source
Autosomal dominant optic atrophy: A novel treatment for <i>OPA1</i> splice defects using U1 snRNA adaption. [PDF]
Jüschke C +5 more
europepmc +1 more source
Engineering Microbial Particles for Next‐Generation Biomedical Platforms
Microbe‐derived particles (MDPs), which include extracellular vesicles, outer membrane vesicles, inclusion bodies, polysaccharide particles, and virus‐like particles, represent a rapidly expanding category of bioinspired nanomaterials. With their natural origin, intrinsic biocompatibility, and highly programmable functionality, MDPs serve as a ...
Yuting Li +7 more
wiley +1 more source
PYC-001, a Peptide Conjugated Oligonucleotide for the Treatment of Autosomal Dominant Optic Atrophy
Autosomal dominant optic atrophy (ADOA) is the most common form of inherited optic neuropathy, characterized by a progressive degeneration of the retinal ganglion cells, leading to bilateral vision loss.
Sri Mudumba; Janya Graynok; Sasiwimon Utama; Tracy Chai; Emily Woodward; Danie Champain; Ferrer Ong; Megan Thorne; Munik Tian; Grace Liu; Maria Kerfoot; Adam Martin; Paula Cunningham; Dean De Alvis
core
CRISPRa-Mediated Increase of OPA1 Expression in Dominant Optic Atrophy. [PDF]
Becchi G +7 more
europepmc +1 more source
Colour-centred Release Hallucinations in a Patient with Early Parkinson's Disease and Unrecognised Autosomal Dominant Optic Atrophy. [PDF]
Hardwick M, Heath D, Saha R, Cooper S.
europepmc +1 more source
Early Retinal UCHL1 Dysregulation Coupled With Synaptic Loss Reflects Alzheimer's Disease Severity
This study identifies synapse‐enriched deubiquitinase UCHL1 as an early Aβ‐responsive regulator of retinal synaptopathy in Alzheimer's disease. Retinal UCHL1 loss accompanies excitatory synapse degeneration, p75NTR activation, and neuroinflammation, and predicts Braak stage and cognitive decline. Aβ42 fibrils trigger synaptic and UCHL1 depletion before
Altan Rentsendorj +25 more
wiley +1 more source
Advances and Perspectives in Graphene‐Based Quantum Dots Enabled Neuromorphic Devices
Graphene‐based QDs are zero‐dimensional carbon nanomaterials with pronounced quantum confinement and tunable electronic structures. Herein, we summarize their synthesis strategies and functionalization methods, and highlight their functional roles and operating mechanisms in devices, as well as recent advances in neuromorphic electronics. We anticipate
Yulin Zhen +9 more
wiley +1 more source
Serum neuronal, glial and mitochondrial markers in autosomal dominant optic atrophy and Leber hereditary optic neuropathy. [PDF]
Rufa A +13 more
europepmc +1 more source

